Sharp tomosynthesis technology may catch breast cancer earlier

Share this article:

A technology that provides three-dimensional (3D) imaging of the breast may represent the next generation in breast cancer detection.

Similar to computed tomography, tomosynthesis acquires multiple, low-dose images at different angles. The images are then used to produce a series of 1-mm-thick slices that can be viewed as a 3D reconstruction of the breast. Features that might be obscured in a traditional two-dimensional mammogram due to overlapping breast anatomy that may mimic or mask a tumor can be easily identified and characterized in the tomosynthesis-produced images. This can reduce the number of false-positive or false-negative findings.

The tomosynthesis unit resembles earlier mammography machines, and the amount of breast compression required is identical to that required for conventional mammography.

University Hospitals (UH) Case Medical Center (Cleveland, Ohio) was involved with early studies of the tomosynthesis technology, and has announced that its patients are among the first in the nation to be offered the system.

“This revolutionary new technology provides exceptionally sharp images and is an important new tool in our arsenal to detect breast cancer early, when it is treatable,” explained Donna Plecha, MD, director of breast imaging at the medical center, in a statement issued by UH Case Medical Center.

Share this article:
You must be a registered member of ONA to post a comment.
close

Next Article in Web Exclusives

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Support team aids decision-making by caregivers of terminal cancer patients

Researchers devised an intervention that quickly integrates a cancer support team to guide caregivers and their patients through difficult end-of-life treatment and decisions.

Protein inhibition opens door for pancreatic cancer treatment

The protein galectin-1 has been identified as a possible therapeutic target for pancreatic cancer; new research has demonstrated that inhibiting this protein in mice with pancreatic cancer increased survival by 20%.

Noninvasive advanced image analysis may improve care for lung cancer patients

Lung cancer patients could receive more precise treatment, and their progress could be better tracked by using a new high-tech method of non-invasive medical imaging analysis, according to a new study.